Computational Modeling Reveals Distinct Effects of HIV and History of Drug Use on Decision-Making Processes in Women

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Vassileva, Jasmin ^a   Ahn, Woo Young ^b   Weber, Kathleen M ^c   Busemeyer, Jerome R ^d   Stout, Julie C ^e   Gonzalez, Raul ^f   Cohen, Mardge H ^c,g  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b VIRGINIA TECH CARILION SCHOOL OF MEDICINE   (United States)

^c Core Center/Cook County Health and Hospital Systems Chicago ^*  (United States)

^d INDIANA UNIVERSITY   (United States)

^e MONASH UNIVERSITY   (Australia)

^f FLORIDA INTERNATIONAL UNIVERSITY   (United States)

^g RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; DIAMORPHINE;

ADULT; ARTICLE; AVERSION; BAYES THEOREM; BEHAVIOR DISORDER; CLINICAL ARTICLE; COMPUTATIONAL MODEL; CONTROLLED STUDY; DECISION MAKING; DRUG ABUSE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; IOWA GAMBLING TASK; LEARNING DISORDER; MATHEMATICAL MODEL; MCHUGH SCHLUGER KELLOGG SCALE; MEDICATION COMPLIANCE; MEMORY DISORDER; MENTAL TASK; NONLINEAR SYSTEM; PROBABILITY; RATING SCALE; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY ANALYSIS; SEXUAL BEHAVIOR; TASK PERFORMANCE;

ADULT; ALGORITHMS; ANTIVIRAL AGENTS; COMPUTER SIMULATION; DECISION MAKING; FEMALE; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; LEARNING; LONGITUDINAL STUDIES; MEMORY; MIDDLE AGED; MODELS, PSYCHOLOGICAL; PATIENT COMPLIANCE; PSYCHOMOTOR PERFORMANCE; READING; SUBSTANCE-RELATED DISORDERS; WECHSLER SCALES;

EID: 84881320367     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0068962     Document Type: Article

References (64)

1. Nath A, Hauser KF, Wojna V, Booze RM, Maragos W, et al. (2002) Molecular basis for interactions of HIV and drugs of abuse. J Acquir Immune Defic Syndr 31 Suppl 2: S62-S69.
2. Heaton RK, Marcotte TD, Mindt MR, Sadek J, Moore DJ, et al. (2004) The impact of HIV-associated neuropsychological impairment on everyday functioning. J Int Neuropsychol Soc 10: 317-331 10.1017/S1355617704102130 [doi];S1355617704102130 [pii].
3. Heaton RK, Franklin DR, Ellis RJ, McCutchan JA, Letendre SL, et al. (2011) HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol 17: 3-16 10.1007/s13365-010-0006-1 [doi].
4. van der Plas EA, Crone EA, van den Wildenberg WP, Tranel D, Bechara A, (2009) Executive control deficits in substance-dependent individuals: a comparison of alcohol, cocaine, and methamphetamine and of men and women. J Clin Exp Neuropsychol 31: 706-719 906024863 [pii];10.1080/13803390802484797 [doi].
5. Hardy DJ, Hinkin CH, Levine AJ, Castellon SA, Lam MN, (2006) Risky decision making assessed with the gambling task in adults with HIV. Neuropsychology 20: 355-360 2006-06643-010 [pii];10.1037/0894-4105.20.3.355 [doi].
6. Martin EM, Pitrak DL, Weddington W, Rains NA, Nunnally G, et al. (2004) Cognitive impulsivity and HIV serostatus in substance dependent males. J Int Neuropsychol Soc 10: 931-938.
7. Bechara A, Dolan S, Denburg N, Hindes A, Anderson SW, et al. (2001) Decision-making deficits, linked to a dysfunctional ventromedial prefrontal cortex, revealed in alcohol and stimulant abusers. Neuropsychologia 39: 376-389 S0028-3932(00)00136-6 [pii].
8. Grant S, Contoreggi C, London ED, (2000) Drug abusers show impaired performance in a laboratory test of decision making. Neuropsychologia 38: 1180-1187 S0028-3932(99)00158-X [pii].
9. Kjome KL, Lane SD, Schmitz JM, Green C, Ma L, et al. (2010) Relationship between impulsivity and decision making in cocaine dependence. Psychiatry Res 178: 299-304 S0165-1781(09)00440-5 [pii];10.1016/j.psychres.2009.11.024 [doi].
10. Rogers RD, Everitt BJ, Baldacchino A, Blackshaw AJ, Swainson R, et al. (1999) Dissociable deficits in the decision-making cognition of chronic amphetamine abusers, opiate abusers, patients with focal damage to prefrontal cortex, and tryptophan-depleted normal volunteers: evidence for monoaminergic mechanisms. Neuropsychopharmacology 20: 322-339 S0893133X98000918 [pii];10.1016/S0893-133X(98)00091-8 [doi].
11. Bechara A, Damasio AR, Damasio H, Anderson SW, (1994) Insensitivity to future consequences following damage to human prefrontal cortex. Cognition 50: 7-15.
12. Bechara A, Damasio H, Damasio AR, Lee GP, (1999) Different contributions of the human amygdala and ventromedial prefrontal cortex to decision-making. J Neurosci 19: 5473-5481.
13. Bechara A, Martin EM, (2004) Impaired decision making related to working memory deficits in individuals with substance addictions. Neuropsychology 18: 152-162 10.1037/0894-4105.18.1.152 [doi];2004-10255-016 [pii].
14. Bolla KI, Eldreth DA, London ED, Kiehl KA, Mouratidis M, et al. (2003) Orbitofrontal cortex dysfunction in abstinent cocaine abusers performing a decision-making task. Neuroimage 19: 1085-1094 S1053811903001137 [pii].
15. Gonzalez R, Bechara A, Martin EM, (2007) Executive functions among individuals with methamphetamine or alcohol as drugs of choice: preliminary observations. J Clin Exp Neuropsychol 29: 155-159 770388106 [pii];10.1080/13803390600582446 [doi].
16. Vassileva J, Gonzalez R, Bechara A, Martin EM, (2007) Are all drug addicts impulsive? Effects of antisociality and extent of multidrug use on cognitive and motor impulsivity. Addict Behav 32: 3071-3076 S0306-4603(07)00116-5 [pii];10.1016/j.addbeh.2007.04.017 [doi].
17. Iudicello JE, Woods SP, Cattie JE, Doyle K, Grant I, (2012) Risky decision-making in HIV-associated neurocognitive disorders (HAND). Clin Neuropsychol 10.1080/13854046.2012.740077 [doi].
18. Thames AD, Streiff V, Patel SM, Panos SE, Castellon SA, et al. (2012) The role of HIV infection, cognition, and depression in risky decision-making. J Neuropsychiatry Clin Neurosci 24: 340-348 1367152 [pii];10.1176/appi.neuropsych.11110340 [doi].
19. Gonzalez R, Vassileva J, Bechara A, Grbesic S, Sworowski L, et al. (2005) The influence of executive functions, sensation seeking, and HIV serostatus on the risky sexual practices of substance-dependent individuals. J Int Neuropsychol Soc 11: 121-131.
20. Stout JC, Busemeyer JR, Lin A, Grant SJ, Bonson KR, (2004) Cognitive modeling analysis of decision-making processes in cocaine abusers. Psychon Bull Rev 11: 742-747.
21. Yechiam E, Kanz JE, Bechara A, Stout JC, Busemeyer JR, et al. (2008) Neurocognitive deficits related to poor decision making in people behind bars. Psychon Bull Rev 15: 44-51.
22. Busemeyer JR, Stout JC, (2002) A contribution of cognitive decision models to clinical assessment: decomposing performance on the Bechara gambling task. Psychol Assess 14: 253-262.
23. Stout JC, Rock SL, Campbell MC, Busemeyer JR, Finn PR, (2005) Psychological processes underlying risky decisions in drug abusers. Psychol Addict Behav 19: 148-157 2005-07161-004 [pii];10.1037/0893-164X.19.2.148 [doi].
24. Fridberg DJ, Queller S, Ahn WY, Kim W, Bishara AJ, et al. (2010) Cognitive Mechanisms Underlying Risky Decision-Making in Chronic Cannabis Users. J Math Psychol 54: 28-38 10.1016/j.jmp.2009.10.002 [doi].
25. Lane SD, Yechiam E, Busemeyer JR, (2006) Application of a computational decision model to examine acute drug effects on human risk taking. Exp Clin Psychopharmacol 14: 254-264 2006-07129-016 [pii];10.1037/1064-1297.14.2.254 [doi].
26. Yechiam E, Hayden EP, Bodkins M, O'Donnell BF, Hetrick WP, (2008) Decision making in bipolar disorder: a cognitive modeling approach. Psychiatry Res 161: 142-152 S0165-1781(07)00209-0 [pii];10.1016/j.psychres.2007.07.001 [doi].
27. Kester HM, Sevy S, Yechiam E, Burdick KE, Cervellione KL, et al. (2006) Decision-making impairments in adolescents with early-onset schizophrenia. Schizophr Res 85: 113-123 S0920-9964(06)00102-2 [pii];10.1016/j.schres.2006.02.028 [doi].
28. Yechiam E, Arshavsky O, Shamay-Tsoory SG, Yaniv S, Aharon J, (2010) Adapted to explore: reinforcement learning in Autistic Spectrum Conditions. Brain Cogn 72: 317-324 S0278-2626(09)00197-3 [pii];10.1016/j.bandc.2009.10.005 [doi].
29. Stout JC, Rodawalt WC, Siemers ER, (2001) Risky decision making in Huntington's disease. J Int Neuropsychol Soc 7: 92-101.
30. Maki PM, Martin-Thormeyer E, (2009) HIV, cognition and women. Neuropsychol Rev 19: 204-214 10.1007/s11065-009-9093-2 [doi].
31. Basso MR, Bornstein RA, (2000) Effects of immunosuppression and disease severity upon neuropsychological function in HIV infection. J Clin Exp Neuropsychol 22: 104-114 10.1076/1380-3395(200002)22:1;1-8;FT104 [doi].
32. Farinpour R, Miller EN, Satz P, Selnes OA, Cohen BA, et al. (2003) Psychosocial risk factors of HIV morbidity and mortality: findings from the Multicenter AIDS Cohort Study (MACS). J Clin Exp Neuropsychol 25: 654-670 10.1076/jcen.25.5.654.14577 [doi].
33. Reavis R, Overman WH, (2001) Adult sex differences on a decision-making task previously shown to depend on the orbital prefrontal cortex. Behav Neurosci 115: 196-206.
34. van den Bos R, den Heijer E, Vlaar S, Houx BB (2007) Exploring gender differences in decision-making using the Iowa Gambling Task. In: Elsworth JE, editors. Psychology of Decision Making in Education, Behavior, and High Risk Situations. Nova Science Publishers. pp. 207-226.
35. Barkan SE, Melnick SL, Preston-Martin S, Weber K, Kalish LA, et al. (1998) The Women's Interagency HIV Study. WIHS Collaborative Study Group. Epidemiology 9: 117-125.
36. Bacon MC, von Wyl V, Alden C, Sharp G, Robison E, et al. (2005) The Women's Interagency HIV Study: an observational cohort brings clinical sciences to the bench. Clin Diagn Lab Immunol 12: 1013-1019 12/9/1013 [pii];10.1128/CDLI.12.9.1013-1019.2005 [doi].
37. Wechsler D (2001) Wechsler Test of Adult Reading. San Antonio, TX: The Psychological Corporation.
38. Kellogg SH, McHugh PF, Bell K, Schluger JH, Schluger RP, et al. (2003) The Kreek-McHugh-Schluger-Kellogg scale: a new, rapid method for quantifying substance abuse and its possible applications. Drug Alcohol Depend 69: 137-150 S0376871602003083 [pii].
39. Tang YL, Khoury L, Bradley B, Gillespie CF, Ressler KJ, et al. (2011) Substance use disorders assessed using the Kreek-McHugh-Schluger-Kellogg (KMSK) scale in an urban low-income and predominantly African American sample of primary care patients. Am J Addict 20: 292-299 10.1111/j.1521-0391.2011.00121.x [doi].
40. Navaline HA, Snider EC, Petro CJ, Tobin D, Metzger D, et al. (1994) Preparations for AIDS vaccine trials. An automated version of the Risk Assessment Battery (RAB): enhancing the assessment of risk behaviors. AIDS Res Hum Retroviruses 10 Suppl 2: S281-S283.
41. Ahn WY, Busemeyer JR, Wagenmakers EJ, Stout JC, (2008) Comparison of decision learning models using the generalization criterion method. Cogn Sci 32: 1376-1402 10.1080/03640210802352992 [doi].
42. Rescorla RA, Wagner AR (1972) A theory of Pavlovian conditioning: variations in the effectiveness of reinforcement and nonreinforcement. In: Black AH, Prokasy WF, editors. Classical Conditioning II: Current Research and Theory. New York, NY: Appleton-Century-Crofts. pp. 64-99.
43. Erev I, Roth A, (1998) Predicting how people play games: Reinforcement learning in experimental games with unique, mixed strategy equilibria. American Economic Review 88: 848-881.
44. Luce R (1959) Individual Choice Behavior. New York, NY: Wiley.
45. Wagenmakers EJ, (2007) A practical solution to the pervasive problems of p values. Psychon Bull Rev 14: 779-804.
46. Kruschke JK (2011) Doing Bayesian Data Analysis: A Tutorial with R and BUGS. Academic Press/Elsevier.
47. Hyman SE, (2005) Addiction: a disease of learning and memory. Am J Psychiatry 162: 1414-1422 162/8/1414 [pii];10.1176/appi.ajp.162.8.1414 [doi].
48. Robbins TW, Ersche KD, Everitt BJ, (2008) Drug addiction and the memory systems of the brain. Ann N Y Acad Sci 1141: 1-21 NYAS1141020 [pii];10.1196/annals.1441.020 [doi].
49. Volkow ND, Fowler JS, Wang GJ, Goldstein RZ, (2002) Role of dopamine, the frontal cortex and memory circuits in drug addiction: insight from imaging studies. Neurobiol Learn Mem 78: 610-624 S1074742702940992 [pii].
50. White NM, (1996) Addictive drugs as reinforcers: multiple partial actions on memory systems. Addiction 91: 921-949.
51. Bolla KI, Eldreth DA, Matochik JA, Cadet JL, (2004) Sex-related differences in a gambling task and its neurological correlates. Cereb Cortex 14: 1226-1232 10.1093/cercor/bhh083 [doi];bhh083 [pii].
52. Cross CP, Copping LT, Campbell A, (2011) Sex differences in impulsivity: a meta-analysis. Psychol Bull 137: 97-130 2011-00025-004 [pii];10.1037/a0021591 [doi].
53. Overman WH, (2004) Sex differences in early childhood, adolescence, and adulthood on cognitive tasks that rely on orbital prefrontal cortex. Brain Cogn 55: 134-147 10.1016/S0278-2626(03)00279-3 [doi];S0278262603002793 [pii].
54. Weller JA, Levin IP, Bechara A, (2010) Do individual differences in Iowa Gambling Task performance predict adaptive decision making for risky gains and losses? J Clin Exp Neuropsychol 32: 141-150 911814017 [pii];10.1080/13803390902881926 [doi].
55. Overman WH, Boettcher L, Watterson L, Walsh K, (2011) Effects of dilemmas and aromas on performance of the Iowa Gambling Task. Behav Brain Res 218: 64-72 S0166-4328(10)00739-4 [pii];10.1016/j.bbr.2010.11.015 [doi].
56. Ersche KD, Fletcher PC, Lewis SJ, Clark L, Stocks-Gee G, et al. (2005) Abnormal frontal activations related to decision-making in current and former amphetamine and opiate dependent individuals. Psychopharmacology (Berl) 180: 612-623 10.1007/s00213-005-2205-7 [doi].
57. Tanabe J, Thompson L, Claus E, Dalwani M, Hutchison K, et al. (2007) Prefrontal cortex activity is reduced in gambling and nongambling substance users during decision-making. Hum Brain Mapp 28: 1276-1286 10.1002/hbm.20344 [doi].
58. Letendre S, Marquie-Beck J, Capparelli E, Best B, Clifford D, et al. (2008) Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system. Arch Neurol 65: 65-70 65/1/65 [pii];10.1001/archneurol.2007.31 [doi].
59. Cysique LA, Maruff P, Brew BJ, (2006) Variable benefit in neuropsychological function in HIV-infected HAART-treated patients. Neurology 66: 1447-1450 66/9/1447 [pii];10.1212/01.wnl.0000210477.63851.d3 [doi].
60. Cysique LA, Vaida F, Letendre S, Gibson S, Cherner M, et al. (2009) Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy. Neurology 73: 342-348 WNL.0b013e3181ab2b3b [pii];10.1212/WNL.0b013e3181ab2b3b [doi].
61. Letendre SL, McCutchan JA, Childers ME, Woods SP, Lazzaretto D, et al. (2004) Enhancing antiretroviral therapy for human immunodeficiency virus cognitive disorders. Ann Neurol 56: 416-423 10.1002/ana.20198[doi].
62. Ciccarelli N, Fabbiani M, Di GS, Fanti I, Baldonero E, et al. (2011) Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients. Neurology 76: 1403-1409 76/16/1403 [pii];10.1212/WNL.0b013e31821670fb [doi].
63. Marra CM, Zhao Y, Clifford DB, Letendre S, Evans S, et al. (2009) Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance. AIDS 23: 1359-1366 10.1097/QAD.0b013e32832c4152 [doi].
64. Simioni S, Cavassini M, Annoni JM, Rimbault AA, Bourquin I, et al. (2010) Cognitive dysfunction in HIV patients despite long-standing suppression of viremia. AIDS 24: 1243-1250 10.1097/QAD.0b013e3283354a7b [doi].